UEDA SEIJI 上田誠二

… Alternative Names

Seiji Ueda 上田誠二

UEDA Seiji 上田誠二

Less

Researcher Number	80322593
Other IDs
Affiliation (Current)	2025: 島根大学, 学術研究院医学・看護学系, 特任教授 2025: 順天堂大学, 医学部, 非常勤講師
Affiliation (based on the past Project Information) *help	2024: 島根大学, 学術研究院医学・看護学系, 特任教授 2023: 順天堂大学, 医学部, 非常勤講師 2022: 順天堂大学, 医学部, 准教授 2018 – 2020: 順天堂大学, 医学部, 准教授 2010 – 2013: Kurume University, 医学部, 准教授 2007 – 2009: Kurume University, 医学部, 講師 2000 – 2006: 久留米大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Kidney internal medicine / Basic Section 59040:Nutrition science and health science-related / Basic Section 53040:Nephrology-related / Kidney internal medicine / Circulatory organs internal medicine Except Principal Investigator Kidney internal medicine / Basic Section 53040:Nephrology-related
Keywords	Principal Investigator 内皮障害 / 慢性腎臓病 / ADMA / 動脈硬化 / 血管内皮障害 / 一酸化窒素 / サルコペニア / 血管新生・修復 / 終末糖化蛋白 / 末梢動脈疾患 … More / AGE / 糖化蛋白 / 血管石灰化 / 虚血再還流 / 造影剤腎症 / 急性腎障害 / 心肥大 / 蛋白尿 / 小胞体ストレス / 間質線維化 / 糸球体硬化 / 酸化ストレス / 心腎連関 / 高血圧 / asymmetric dimethylarginine / NO / 慢性腎疾患 / Asmmetric dimethylariginine / 心血管病 / 慢種腎臓病 / Cardiac hypertrophy / Renal failure / PRMT / Hypertension / Nitric oxide / DDAH / CKD / Interleukin-4 / SLE / lupus nephritis / Inferleukin-4 / 血管内皮 / インターロイキン / サイトカイン / ジメチルアルギニン / 血管平滑筋 … More Except Principal Investigator ADMA / DDAH / 内皮機能障害 / CKD / 慢性腎臓病 / 腎虚血再灌流 / 終末糖化産物受容体 / ミネラルコルチコイド受容体 / 急性腎障害 / 脂肪細胞 / 微量アルブミン尿 / 心腎連関 / 内皮障害 / インスリン抵抗性 / メタボリック症候群 / NO / 心血管病 / ADMA DDAH / 蛋白尿 / 一酸化窒素 / podocyte / AGE / Diabetic Nephropathy / 尿蛋白 / 尿細管間質 / MMP-2 / 細胞外基質 / 糖尿病性腎症 Less

Roles of Irisin, a myokine in uremiac sarcopeniaPrincipal Investigator
- Principal Investigator
  
  上田誠二
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 59040:Nutrition science and health science-related
- Research Institution
  Shimane University
急性腎障害におけるミネラルコルチコイド受容体を標的とした新規治療戦略の開発
- Principal Investigator
  
  若林啓一
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Juntendo University
IgA腎症モデルマウスにおけるエンドセリン受容体拮抗薬による腎保護作用の解析
- Principal Investigator
  
  中田真実
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Juntendo University
Involvements of advanced glycation end products on the developments of peripheral arterial disease in CKD patientsPrincipal Investigator
- Principal Investigator
  
  Seiji Ueda
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Juntendo University
Role of ADMA in acute kidney injuryPrincipal Investigator
- Principal Investigator
  
  SEIJI Ueda
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
Missing link between metabolic syndrome and chronic kidney disease.?Role of asymmetric dimethylarginine-
- Principal Investigator
  
  OKUDA Seiya
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
Role of asymmetric dimethylarginine in cardio-renal syndromePrincipal Investigator
- Principal Investigator
  
  UEDA Seiji
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
Tubulointerstitial injury is exacerbated in streptozotocin-induced diabetic matrix metalloproteinase-2 knockout mice
- Principal Investigator
  
  FUKAMI Kei
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
ADMA metabolism and microvascular damage in chronic renal diseases
- Principal Investigator
  
  OKUDA Seiya
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
内因性一酸化窒素合成酵素酵素阻害物質蓄積抑制による慢性腎疾患進展予防Principal Investigator
- Principal Investigator
  
  上田誠二
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
腎不全進展におけるasymmetric dimethylarginineの役割Principal Investigator
- Principal Investigator
  
  上田誠二
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
ループス腎炎発症・進展におけるInterleukin-4(IL-4)の役割Principal Investigator
- Principal Investigator
  
  上田誠二
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Kurume University
生体内NO産生調整システムとしてのADMA-DDAH系Principal Investigator
- Principal Investigator
  
  上田誠二
- Project Period (FY)
  2000 – 2001
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Circulatory organs internal medicine
- Research Institution
  Kurume University

[Book] Cell Growth Processes : New research2008
- Author(s)
  Ueda S, Okuda S
- Publisher
  Nova publisher
- Data Source
  KAKENHI-PROJECT-19590971
[Book] Cell Growth Processes : New Research. Implication of asymmetric dimethylariginine (ADMA) in cell growth process in atherosclerosis2008
- Author(s)
  Ueda S, et al.
- Total Pages
  15
- Publisher
  Nova publishers
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Fractional excretion of tumor necrosis factor receptor?1 and 2 in patients with type?2 diabetes and normal renal function2021
- Author(s)
  Gohda Tomohito、Kamei Nozomu、Kubota Mitsunobu、Tanaka Kanako、Yamashita Yoshinori、Sakuma Hiroko、Kishida Chiaki、Adachi Eri、Koshida Takeo、Murakoshi Maki、Hagiwara Shinji、Funabiki Kazuhiko、Ueda Seiji、Suzuki Yusuke
- Journal Title
  
  Journal of Diabetes Investigation
  
  Volume: 12 Issue: 3 Pages: 382-389
- DOI
  10.1111/jdi.13351
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08617, KAKENHI-PROJECT-18K08251
[Journal Article] Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease.2020
- Author(s)
  Yabuuchi、J., Ueda, S., Yamagishi, S-I, Nohara, N., Nagasawa, H., Wakabayashi, K., Matsui, T., Higashimoto Y., Kadoguchi, T., Otsuka, T., Gohda, T., Suzuki, Y.
- Journal Title
  
  Sci. Rep.
  
  Volume: 10 Issue: 1 Pages: 17647-17659
- DOI
  10.1038/s41598-020-74673-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K06574, KAKENHI-PROJECT-19K17718, KAKENHI-PROJECT-18K08251, KAKENHI-PROJECT-18K17935
[Journal Article] Uremic Toxin–Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome2019
- Author(s)
  Taguchi Kensei、Elias Bertha C.、Brooks Craig R.、Ueda Seiji、Fukami Kei
- Journal Title
  
  Circ J
  
  Volume: 84 Issue: 1 Pages: 2-8
- DOI
  10.1253/circj.CJ-19-0872
- NAID
  130007772709
- ISSN
  1346-9843, 1347-4820
- Year and Date
  2019-12-25
- Language
  English
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08251, KAKENHI-PROJECT-19K08693, KAKENHI-PROJECT-17K16106
[Journal Article] Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease2019
- Author(s)
  Gohda Tomohito、Kamei Nozomu、Koshida Takeo、Kubota Mitsunobu、Tanaka Kanako、Yamashita Yoshinori、Adachi Eri、Ichikawa Saki、Murakoshi Maki、Ueda Seiji、Suzuki Yusuke
- Journal Title
  
  Journal of Diabetes Investigation
  
  Volume: 11 Issue: 2 Pages: 435-440
- DOI
  10.1111/jdi.13139
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08251
[Journal Article] Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease.2018
- Author(s)
  Takahashi K, Ueda S, Kobayashi T, Nishiyama A, Fujisawa Y, Sugaya T, Shiota S, Takahashi K, Gohda T, Horikoshi S, Suzuki Y.
- Journal Title
  
  Sci Rep
  
  Volume: 18 Issue: 1 Pages: 17926-17926
- DOI
  10.1038/s41598-018-36159-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08251
[Journal Article] Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-42018
- Author(s)
  Kaifu Kumiko、Ueda Seiji、Nakamura Nobutaka、Matsui Takanori、Yamada-Obara Nana、Ando Ryotaro、Kaida Yusuke、Nakata Masami、Matsukuma-Toyonaga Maki、Higashimoto Yuichiro、Fukami Kei、Suzuki Yusuke、Okuda Seiya、Yamagishi Sho-ichi
- Journal Title
  
  Microvascular Research
  
  Volume: 120 Pages: 90-93
- DOI
  10.1016/j.mvr.2018.07.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08968, KAKENHI-PROJECT-18K08251, KAKENHI-PROJECT-16K07101, KAKENHI-PROJECT-16K07307, KAKENHI-PROJECT-16K09637
[Journal Article] Role of asymmetric dimethylarginine incardiorenal syndrome2014
- Author(s)
  Ueda S, Yamagishi S, Okuda S
- Journal Title
  
  Curr Pharm Design
  
  Volume: 20 Pages: 2448-55
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Role of Asymmetric Dimethylarginine in Cardiorenal Syndrome.2014
- Author(s)
  Ueda S, et al.
- Journal Title
  
  Curr Pharm Des
  
  Volume: 20 Pages: 2448-2455
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury2014
- Author(s)
  Nakayama Y, UedaS, Yamagishi S, Okuda S
- Journal Title
  
  Kidney Int
  
  Volume: 85 Pages: 570-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.2014
- Author(s)
  Nakayama Y, Ueda S, et al.
- Journal Title
  
  Kidney Int
  
  Volume: 85 Issue: 3 Pages: 570-578
- DOI
  10.1038/ki.2013.398
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591210, KAKENHI-PROJECT-25461239
[Journal Article] Involvement of advanced glycation end product–induced asymmetric dimethylarginine generation in endothelial dysfunction2013
- Author(s)
  Ando R, Ueda S, et al.
- Journal Title
  
  Diabetes & Vascular Disease Research
  
  Volume: 印刷中 Issue: 5 Pages: 436-441
- DOI
  10.1177/1479164113486662
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Role of asymmetric dimethylargine in cardiorenal syndrome2013
- Author(s)
  Ueda S, Okuda S, et al.
- Journal Title
  
  Current Pharmaceutical Design
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Role of asymmetric dimethylargine in cardiorenal syndrome2013
- Author(s)
  Ueda S, et al.
- Journal Title
  
  Current Pharmaceutical Design
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction2013
- Author(s)
  Ando R, Ueda S, Yamagishi S, Miyazaki H, Kaida Y, Kaifu K, Yokoro M, Nakayama Y, Obara N, Fukami K, Takeuchi M, Okuda S
- Journal Title
  
  Diab Vasc Dis Res
  
  Volume: 10(5) Pages: 436-41
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.2012
- Author(s)
  Kajimoto H, Kai H, Aoki H, Yasuoka S, Anegawa T, Aoki Y, Ueda S, Okuda S, Imaizumi T
- Journal Title
  
  Kidney Int.
  
  Volume: 81(8) Pages: 762-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Pravastatin inhibits advanced glycation end products (AGEs)‐induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level2012
- Author(s)
  Ishibashi Y, Yamagishi S, Matsui T, Ohta K, Tanoue R, Takeuchi M, Ueda S, Nakamura K, Okuda S
- Journal Title
  
  Metabolism
  
  Volume: 61(8) Pages: 1067-72
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Inhibition of eNOS Phosphorylation Mediates Endothelial Dysfunction in Renal Failure : New Effect of Asymmetric Dimethylarginine2012
- Author(s)
  Kajimoto H, Kai H, Aoki H, Yasuoka S, Anegawa T, Aoki Y, Ueda S, Okuda S, Imaizumi T
- Journal Title
  
  Kidney Int
  
  Volume: 81 Pages: 762-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpressionin a rat model of nephrotic syndrome.2012
- Author(s)
  Kaida Y, Ueda S, Yamagishi S, Nakayama Y, Ando R, Iwatani R, Fukami K, Okuda S.
- Journal Title
  
  Life Sci.
  
  Volume: 91(9-10) Pages: 301-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome2012
- Author(s)
  Kaida Y, Ueda S, Yamagishi SI, Nakayama Y, Ando R, Iwatani R, Fukami K, Okuda S
- Journal Title
  
  Life Sci
  
  Volume: 24;91(9-10) Pages: 301-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes2012
- Author(s)
  Yamagishi SI, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S
- Journal Title
  
  Biochim Biophys Acta
  
  Volume: 1820(5) Pages: 663-71
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Inhibition of eNOS Phosphorylation Mediates Endothelial Dysfunction in Renal Failure : New Effect of Asymmetric Dimethylarginine2012
- Author(s)
  Kajimoto H, Kai H, Imaizumi T(他6人9番目)
- Journal Title
  
  Kidney International
  
  Volume: 81 Issue: 8 Pages: 762-768
- DOI
  10.1038/ki.2011.476
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21390249, KAKENHI-PROJECT-22590565, KAKENHI-PROJECT-22590903, KAKENHI-PROJECT-22791042, KAKENHI-PROJECT-23591210, KAKENHI-PROJECT-24390334, KAKENHI-PROJECT-24659640
[Journal Article] Association of ADMA with severity of kidney injury and decline in kidney function in IgA nephropathy.2011
- Author(s)
  Fujimi-Hayashida A, Ueda S, Yamagishi S, Kaida Y, Ando R, Nakayama Y, Fukami K, Okuda S.
- Journal Title
  
  Am J Nephrol
  
  Volume: 33 Pages: 1-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients2011
- Author(s)
  Nagano M, Fukami K, Yamagishi S, Sakai K, Kaida Y, Matsumoto T, Hazama T, Tanaka M, Ueda S, Okuda S
- Journal Title
  
  Nephrology (Carlton)
  
  Volume: 16 Pages: 299-303
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] Association of ADMA with severity of kidney injury and decline in kidney function in IgA nephropathy.2011
- Author(s)
  Fujimi-Hayashida A, Ueda S, Yamagishi S, Kaida Y, Ando R, Nakayama Y, Fukami K, Okuda S.
- Journal Title
  
  Am J Nephrol. 33
  
  Pages: 1-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Association of asymmetric dimethylarginine with severity ofkidney injury and decline in kidney function in IgA nephropathy.2011
- Author(s)
  Fujimi-Hayashida A, Ueda S, Yamagishi S, Kaida Y, Ando R, Nakayama Y, Fukami K, Okuda S.
- Journal Title
  
  Am J Nephrol.
  
  Volume: 33(1) Pages: 1-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Association of asymmetric dimethylarginine with severity of kidney injury and decline in kidney function in IgA nephropathy.2011
- Author(s)
  Fujimi-Hayashida A, Ueda S, et al.
- Journal Title
  
  Am J Nephrol.
  
  Volume: 33 Pages: 1-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Association of ADMA with severity of kidney injury and decline in kidney function in IgA nephropathy2011
- Author(s)
  Fujimi-Hayashida A, Ueda S, Yamagishi S, Kaida Y, Ando R, Nakayama Y, Fukami K, Okuda S
- Journal Title
  
  Am J Nephrol
  
  Volume: 33 Pages: 1-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591210
[Journal Article] New pathways to renal damage : Role of ADMA for retarding renal disease progression.2010
- Author(s)
  Ueda S, Yamagishi S, Okuda S.
- Journal Title
  
  J Nephrol.
  
  Pages: 377-386
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] New pathways to renal damage : Role of ADMA for retarding renal disease progression2010
- Author(s)
  Ueda S, Yamagishi S, Okuda S.
- Journal Title
  
  J Nephrol. (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] New pathways to renal damage : Role of ADMA for retarding renal disease progression.2010
- Author(s)
  Ueda S, Yamagishi S, Okuda S.
- Journal Title
  
  J Nephrol 23
  
  Pages: 377-386
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Irbesartan inhibits advanced glycation end product(AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs(RAGE)expression2010
- Author(s)
  Matsui T, Yamagishi SI, Takeuchi M, Ueda S, Fukami K
- Journal Title
  
  Pharmacol Res 61
  
  Pages: 34-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] New pathways to renal damage: role of ADMA in retarding renal disease progression.2010
- Author(s)
  Ueda S, Yamagishi S, Okuda S.
- Journal Title
  
  J Nephrol.
  
  Volume: 23(4) Pages: 377-86
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease2009
- Author(s)
  Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.
- Journal Title
  
  (CKD) Life Sciences 84
  
  Pages: 853-856
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation2009
- Author(s)
  Matsui T, Yamagishi S, Takeuchi M, Ueda S, Fukami K, Okuda S.
- Journal Title
  
  Biochem Biophys Res Commun. 385
  
  Pages: 269-72
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Involvement of asymmetric dimethylarginine(ADMA)in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease(CKD)2009
- Author(s)
  Ueda S, et al.
- Journal Title
  
  Life Sciences 84
  
  Pages: 853-856
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Positive association of serum levels of advanced glycation end products (AGEs) and high mobility group box-1 (HMGB-1) with asymmetric dimethylarginine (ADMA) in non-diabetic chronic kidney disease patients.2009
- Author(s)
  Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Ueda Y, Suzuki T, Yamada S, Takeuchi M, Fukami K, Ueda S, Adachi H, Matsui T, Okuda S, Yamagishi S.
- Journal Title
  
  Metabolism 58
  
  Pages: 1624-1628
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Involvement of asymmetric dimethylarginine(ADMA)in tubulointerstitial ischemia in early phase of diabetic nephropathy2009
- Author(s)
  Shibata R, Ueda S, et al.
- Journal Title
  
  Nephrol Dial Transplant. 24
  
  Pages: 1162-1169
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.2009
- Author(s)
  Nakamura T, Sata E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamada S, Shoji H, Takeuchi M, Matsui T, Ueda S, Adachi H, Okuda S, Yamagishi S.
- Journal Title
  
  Pharmacol.Res. 60
  
  Pages: 515-518
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.2009
- Author(s)
  Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Ueda Y, Suzuki T, Yamada S, Takeuchi M, Fukami K, Ueda S, Adachi H, Matsui T, Okuda S
- Journal Title
  
  Yamagishi SI. Metabolism. 3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a ratmodel of chronic kidney disease (CKD).2009
- Author(s)
  Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.
- Journal Title
  
  Life Sci.
  
  Volume: 84(23-24) Pages: 853-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article]2009
- Author(s)
  Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
- Journal Title
  
  Nephrol Dial Transplant.
  
  Volume: 24(4) Pages: 1162-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.2009
- Author(s)
  Fujimura T, Yamagishi SI, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura KI, Okuda S.
- Journal Title
  
  Nephrol Dial Transplant. 24
  
  Pages: 1397-406
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Ezetimibe decrease serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner.2009
- Author(s)
  Nakamura T, Sata E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Ueda S, Adachi H, Okuda S, Yamagishi S.
- Journal Title
  
  Pharmacol Res. 60
  
  Pages: 525-528
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) tubulointerstitial ischemia in early phase of diabetic nephropathy.2009
- Author(s)
  Shibata R, Ueda S, et al.
- Journal Title
  
  Nephrol Dial Transplant. 24
  
  Pages: 1162-1169
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease.2009
- Author(s)
  Ueda S, et al
- Journal Title
  
  Life Sciences (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)2009
- Author(s)
  Ueda S, Yamagishi SI, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.
- Journal Title
  
  Life Sci. 84
  
  Pages: 853-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischemia in early phase of diabetic nephropathy.2009
- Author(s)
  Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
- Journal Title
  
  Nephrol Dial Transplant. 24
  
  Pages: 1162-1169
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.2009
- Author(s)
  Matsui T, Yamagishi SI, Takeuchi M, Ueda S, Fukami K, Okuda S.
- Journal Title
  
  Pharmacol Res. 25
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] A case of acute kidney injury related to intravenous Zoledronic acid in a patient with multiple myeloma. Kiyomi Koike, Kei Fukami2009
- Author(s)
  Satoshi Morishige, Takuma Hazama, Kensei Taguchi, Ryotaro Ando, Makio Nagano, Jyunko Yoshimura, Seiji Ueda, Michitoshi Hashiguchi, Kiyoshi Tamaki, Hidemi Nishida
- Journal Title
  
  Seiya Okuda. Nippon Jinzo Gakkai Shi. 51
  
  Pages: 557-62
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.2009
- Author(s)
  Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hyayashida A, Koike K, Matsui T, Nakamura K, Okuda S.
- Journal Title
  
  Nephrol Dial Transplant. 24
  
  Pages: 1397-1406
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease2009
- Author(s)
  Nagano M, Fukami K, Yamagishi S, Ueda S, Kaida Y, Matsumoto T, Yoshimura J, Hazama T, Takamiya Y, Kusumoto T, Gohara S, Tanaka H, Adachi H, Okuda S.
- Journal Title
  
  Am J Nephrol 29
  
  Pages: 109-15
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Clinical utility of acarbose, alpha-glucosidase inhibitor on cardiometabolic disorders.2009
- Author(s)
  Yamagishi S, Matsui T, Ueda S, Fukami K, Okuda S.
- Journal Title
  
  Curr Drug Metab. 10
  
  Pages: 159-163
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischemia in early phase of diabetic nephropathy.2009
- Author(s)
  Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
- Journal Title
  
  Nephrol Dial Transplant. 24
  
  Pages: 1162-1169
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.2009
- Author(s)
  Shibata R, Ueda S, Yamagishi SI, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
- Journal Title
  
  Nephrol Dial Transplant. 24
  
  Pages: 1162-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Clinical Utility of Acarbose, an alpha-Glucosidase Inhibitor in Cardiometabolic Disorders2009
- Author(s)
  Yamagishi S, Matsui T, Ueda S, Fukami K, Okuda S.
- Journal Title
  
  Curr Drug Metab. 10
  
  Pages: 159-63
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.2008
- Author(s)
  Yamagishi SI, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Fukami K, Okuda S, Imaizumi T.
- Journal Title
  
  Microvasc Res. 75
  
  Pages: 130-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression2008
- Author(s)
  Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Fukami K, Okuda S, Imaizumi T.
- Journal Title
  
  Microvasc Res. 75
  
  Pages: 130-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Aqueous humor levels of asymmetric dimethylarginine (ADMA) are positively associated with monocyte chemoattractant protein-1 (MCP-1) in patients with uveitis.2008
- Author(s)
  Yoshida Y, Yamagishi S, Ueda S, Okuda S, Yamakawa R.
- Journal Title
  
  Br J Ophthalmol. 92(1)
  
  Pages: 93-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.2008
- Author(s)
  Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S.
- Journal Title
  
  Curr Pharm Des. 14
  
  Pages: 962-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Pleiotropic effects of atorvastatin of vascular injury in diabetes.2008
- Author(s)
  Yamagishi S, Nakamura K, Matsui T, Ueda S, Fukami K, Okuda S.
- Journal Title
  
  BDL Cholesterol: Targets, Control and Therapy.
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression2008
- Author(s)
  Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Fukami K, Okuda S, Imaizumi T.
- Journal Title
  
  Microvasc Res 75
  
  Pages: 130-134
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications.2008
- Author(s)
  Yamagishi S, Ueda S, Nakamura K, Matsui T, Okuda S.
- Journal Title
  
  Curr Pharm Des 14
  
  Pages: 2613-2618
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications.2008
- Author(s)
  Yamagishi S, Nakamura K, Matsui T, Ueda S, Fukami K, Okuda S.
- Journal Title
  
  Expert Opin Investig Drugs. 17
  
  Pages: 983-96
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Implication of asymmetric dimethylarginine (ADMA) in endothelial cell growth process in atherosclerosis.2008
- Author(s)
  Ueda S, Yamagishi S, Fukami K, Hayashida A, Kaida Y, Takamiya Y, Okuda S.
- Journal Title
  
  Cell Growth Processes: New Research. (Nova publishers) Chapter IV
  
  Pages: 123-137
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of AGEs in diabetic nephropathy.2008
- Author(s)
  Fukami K, Yamagishi S, Ueda S, Okuda S.
- Journal Title
  
  Current Pharm Design 14
  
  Pages: 946-952
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.2008
- Author(s)
  Yamagishi S, Ueda S, et al
- Journal Title
  
  Curr Pharm Des 14
  
  Pages: 2613-2618
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Aqueous humor levels of asymmetric dimethylarginine (ADMA) are positively associated with monocyte chemoattractant protein-1 (MCP-1) in patients with uveitis.2008
- Author(s)
  Yoshida Y, Yamagishi S, Ueda S, Okuda S, Yamakawa R.
- Journal Title
  
  Br J Ophthalmol. 92(1)
  
  Pages: 93-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590969
[Journal Article] Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications2008
- Author(s)
  Yamagishi S, Nakamura K, Matsui T, Ueda S, Fukami K, Okuda S.
- Journal Title
  
  Expert Opin Investig Drugs. 17
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Circulating Matrix Metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease.2008
- Author(s)
  Nagano M, Fukami K, Yamagishi SI, Ueda S, Kaida Y, Matsumoto T, Yoshimura J, Hazama T, Takamiya Y, Kusumoto T, Gohara S, Tanaka H, Adachi H, Okuda S.
- Journal Title
  
  Am J Nephrol. 29
  
  Pages: 109-115
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of AGEs in diabetic nephropathy2008
- Author(s)
  Fukami K, Yamagishi S, Ueda S, Okuda S.
- Journal Title
  
  Curr Pharm Des. 14
  
  Pages: 946-52
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications.2008
- Author(s)
  Yamagishi S, Ueda S, Nakamura K, Matsui T, and Okuda S.
- Journal Title
  
  Curr Pharm Des 14
  
  Pages: 2613-2618
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Aqueous humor levels of asymmetric dimethylarginine (ADMA) are correlated with pigment epithelium-derived factor (PEDF) in patients with uveitis.2007
- Author(s)
  Yoshida Y, Yamagishi S, Ueda S, Yoshimura K, Okuda S, Yamakawa R.
- Journal Title
  
  J Int Med Res 35
  
  Pages: 892-895
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Asymmetric dimethylarginine(ADMA)may be a missing link between cardiovascular disease (CVD) and chronic kidney disease (CKD).2007
- Author(s)
  Ueda S, et. al.
- Journal Title
  
  Nephrology 12
  
  Pages: 582-590
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes2007
- Author(s)
  Yamagishi S, Ueda S, Okuda S.
- Journal Title
  
  Med Hypotheses 69
  
  Pages: 922-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Olmesartan blocks advanced glycation end product (AGE)-evoked inflammatory reactions in endothelial cells by suppressing reactive oxygen species generation.2007
- Author(s)
  Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Okuda S, Imaizumi T.
- Journal Title
  
  Ophthalmic Res 40
  
  Pages: 10-15
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Food-derived advanced glycation end products (AGEs): A novel therapeutic target for various disorders.2007
- Author(s)
  Yamagishi S, Ueda S, Okuda S.
- Journal Title
  
  Current Pharmaceutical Design 13
  
  Pages: 2832-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of asymmetric dimethylarginine (ADMA) in chronic kidney disease2007
- Author(s)
  Ueda S, Yamagishi S, Matsumoto Y, Okuda S.
- Journal Title
  
  Current Enzyme Inhibition 3
  
  Pages: 284-290
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Asymmetric dimethylarginine (ADMA) is a novel and emerging risk factor for cardiovascular disease and development of renal injury in chronic kidney disease.2007
- Author(s)
  Ueda S, et al.
- Journal Title
  
  J Am Soc Nephrol. (In press)
- NAID
  10024140370
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Possible involvument of AGE and MMP-2 in podocyte detachment and loss2007
- Author(s)
  Kei Fukami, Sho-ichi Yamagishi, Seiji Ueda, Hiroshi Kawachi, Masavoshi Takeuchi, Seiya Okuda
- Journal Title
  
  Journal of the American Society of Nephrology 18
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.2007
- Author(s)
  Yamagishi S, Fukami K, Ueda S, Okuda S.
- Journal Title
  
  Current Drug Targets 8
  
  Pages: 952-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation.2007
- Author(s)
  Kaneyuki U, Ueda S, Yamagishi SI, Kato S, Fujimura T, Shibata R, Hayashida A, Yoshimura J, Kojiro M, Oshima K, Okuda S.
- Journal Title
  
  Vascul Pharmacol. 46
  
  Pages: 286-292
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.2007
- Author(s)
  Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.
- Journal Title
  
  J Am Soc Nephrol. 18
  
  Pages: 1525-1533
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Asymmetric dimethylarginine (ADMA) and endothelial dysfunction in patients with chronic kidney disease.2007
- Author(s)
  Ueda S, Yamagishi S, Takamiya Y, Kaida Y, Okuda S.
- Journal Title
  
  Research Advances in Nephrology. 1
  
  Pages: 1-12
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes2007
- Author(s)
  Yamagishi S, Ueda S, et al.
- Journal Title
  
  Med Hypotheses (In press)
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Novel therapeutic targets for diabetic nephropathy2007
- Author(s)
  Kei Fukami, Sho-ichi Yamagishi, Seiji Ueda, Seiya Okuda
- Journal Title
  
  Endocr Metab ImmuneDisord Drug Targets 7
  
  Pages: 83-92
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Asymmetric dimethylarginine (ADMA) may be a missing link between cardiovascular disease (CVD) and chronic kidney disease (CKD).2007
- Author(s)
  Ueda S, Yamagishi S, Kaida Y, Okuda S.
- Journal Title
  
  Nephrology 12
  
  Pages: 582-590
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and development of renal injury in chronic kidney disease.2007
- Author(s)
  Ueda S, Yamagishi S, Matsumoto Y, Fukami K, Okuda S.
- Journal Title
  
  Clin Exp Nephrol 11
  
  Pages: 115-121
- NAID
  10024140370
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Adult-onset acute tubulointerstitial nephritis and uveitis with fanconi syndrome. Case report and review of the literature.2007
- Author(s)
  Koike K, Iida S, Usui M, Matsumoto Y, Fukami K, Ueda S, Tamaki K, Kato S, Okuda S.
- Journal Title
  
  Clin Nephrol. 67
  
  Pages: 255-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of asymmetric dimethylarginine (ADMA) in chronic kidney disease.2007
- Author(s)
  Ueda S, et al.
- Journal Title
  
  Current Enzyme Inhibition (In press)
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Role of AGEs in Diabetic Nephropathy2007
- Author(s)
  Kei Fukami, Sho-ichi Yamagishi, Seiji Ueda, Seiya Okuda
- Journal Title
  
  Current Pharmaceutical Design (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590970
[Journal Article] Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a ral model of chronic kidney disease2007
- Author(s)
  Mateumoto Y, Ueda S, et. al.
- Journal Title
  
  J Am Soc Nephrol 18
  
  Pages: 1525-1533
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Dimethylarginine, dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.2007
- Author(s)
  Matsumoto Y, Ueda S, et al.
- Journal Title
  
  J Am Soc Nephrol. (In press)
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Novel therapeutic targets for diabetic nephropathy.2007
- Author(s)
  Fukami K, Yamagishi S, Ueda S, Okuda S.
- Journal Title
  
  Endocr Metab Immune Disord Drug Targets 7
  
  Pages: 83-92
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of asymmetric dimethylarginine (ADMA) in chronic kidney disease2007
- Author(s)
  Ueda s, et. al.
- Journal Title
  
  Current Enzyme Inhibition 3
  
  Pages: 284-290
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Pigment epithelium-derived factor prevents advanced glycation end products-elicited endothelial nitric oxide synthase reduction through its ant-oxidative properties.2007
- Author(s)
  Yamagishi S, Ueda S, Matsui T, Nakamura K, Imaizumi T, Takeuchi M, Okuda S.
- Journal Title
  
  Protein Pept Lett 14
  
  Pages: 832-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.2006
- Author(s)
  Matsuguma K, Ueda S, et al.
- Journal Title
  
  J Am Soc Nephrol. 17
  
  Pages: 2176-2183
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Asymmetric dimethylarginine (ADMA) and cardiovascular disease.2006
- Author(s)
  Ueda S, et al.
- Journal Title
  
  Vasc Dis Prevent 3
  
  Pages: 291-295
- Data Source
  KAKENHI-PROJECT-18790582
[Journal Article] Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase : a novel anti-oxidative mechanism of PEDF.2005
- Author(s)
  Yamagishi S, Nakamura. K, Ueda S, et al.
- Journal Title
  
  Cell Tissue Res. 320
  
  Pages: 437-445
- Data Source
  KAKENHI-PROJECT-16790479
[Journal Article] Adenoviral over-expression of dimethylarginine dimethylaminohydrolase reduces systemic endogenous nitric oxide synthase inhibitor level with the improvement of renal function tubulointerstitial hypoxia in the rat remnant kidney model2005
- Author(s)
  Matsumoto Y, Ueda S, et al.
- Journal Title
  
  J Am Soc Nephrol 16
- Data Source
  KAKENHI-PROJECT-16790479
[Journal Article] Anti-hypertensive argents ameliorate ischemic tubulointerstitial injury with decreased endogenous nitric oxide synthase inhibitor accumulation in the animal model of diabetes mellitus2005
- Author(s)
  Shibata R, Ueda S, et al.
- Journal Title
  
  J Am Soc Nephrol 16
- Data Source
  KAKENHI-PROJECT-16790479
[Journal Article] Endogenous nitric oxide inhibitor accumulation by impaired dimethylarginine dimethylaminohydrolase activity accelerates hypertension and cardiac hypertrophy in the rat remnant kidney model2005
- Author(s)
  Ueda S, et al.
- Journal Title
  
  J Am Soc Nephrol 16
- Data Source
  KAKENHI-PROJECT-16790479
[Journal Article] 糖尿病性腎不全患者における終末糖化蛋白による血管内皮傷害機序の検討2004
- Author(s)
  上田他
- Journal Title
  
  日本腎臓学会誌 46・3
  
  Pages: 187-187
- Data Source
  KAKENHI-PROJECT-16790479
[Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)
- Author(s)
  Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.
- Journal Title
  
  Life Sciences in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590971
[Journal Article] Role of asymmetric dimetylarginine in cardiorenal syndrome.
- Author(s)
  Ueda S, Yamagishi S, Yokoro M, Okuda S.
- Journal Title
  
  Current Pharmaceutical Design
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Involvement of advanced glycation end product?induced asymmetric dimethylarginine generation in endothelial dysfunction.
- Author(s)
  Ando R, Ueda S, Yamagishi S, Miyazaki H, Kaida Y, Kaifu K, Yokoro M, Nakayama Y, Obara N, Fukami K, Takeuchi M, Okuda S.
- Journal Title
  
  Diabetes & Vascular Disease Research.
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590903
[Journal Article] Asymmetric dimethylarginine (ADMA) and cardiovascular disease.
- Author(s)
  Ueda S, et al.
- Journal Title
  
  Vasc Dis Prevention. in press
- Data Source
  KAKENHI-PROJECT-16790479
[Presentation] HMGB1/RAGEシグナルを介したミネラルコルチコイド受容体の活性化はAKIモデルマウスの腎障害発症に関与する2023
- Author(s)
  大塚智之、上田誠二、長澤肇、大熊輝之、中田真実、若林啓一、村越真紀、小林敬、松井孝憲、山岸昌一、合田朋仁、鈴木祐介
- Organizer
  第45回日本高血圧学会総会
- Data Source
  KAKENHI-PROJECT-23K07706
[Presentation] 尿毒素AGEsは腎不全患者サルコペニア／フレイル発症・進展へ寄与する2021
- Author(s)
  上田誠二
- Organizer
  第11回　日本リハビリテーション学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] CKDにおけるサルコペニア/フレイルの発症因子としてのAGE2020
- Author(s)
  21.薮内純子、上田誠二、野原奈緒、長澤肇、大塚智之、若林啓一、鈴木祐介
- Organizer
  第63回日本腎臓学会学術総会
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] 透析患者の血管石灰化における終末糖化産物（AGEs）、慢性炎症の役割の解明2019
- Author(s)
  長澤肇、上田誠二、薮内純子、小林敬、金口泰彦、高橋敬子、合田朋仁、山岸昌一、鈴木祐介
- Organizer
  第9回日本腎臓リハビリテーション学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] 臓器連関機序としての内因性NO合成酵素阻害物質ADMAの役割2019
- Author(s)
  上田誠二
- Organizer
  第19回日本NO学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] 透析患者におけるサルコペニア/フレイルの発症因子としてのADMA2019
- Author(s)
  藪内純子、上田誠二、長澤肇、高橋敬子、大塚智之、鈴木祐介
- Organizer
  第53回日本成人病（生活習慣病）学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] Roles of chronic inflammation and AGEs in the development of vascular calcification in chronic hemodialysis patients.2019
- Author(s)
  Otsuka T, Nagasawa H, Ueda S, Suzuki H, Yamagishi S, Suzuki Y
- Organizer
  56th ERA-EDTA Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] 透析患者における終末糖化蛋白AGEｓと心血管病、サルコペニアとの関連の解析2019
- Author(s)
  上田誠二、藪内純子、長澤肇、大塚智之、小林敬、海部久美子、鈴木仁、合田朋仁、松井孝憲、山岸昌一、鈴木祐介
- Organizer
  第42回日本高血圧学会総会
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] Involvements of AGEs on vascular calcification in hemodialysis patients.2018
- Author(s)
  Nagasawa H, Ueda S, Yabuuchi J, Kobayashi T, Kanaguchi Y, Takahashi K, Yamagishi S, Suzuki Y.
- Organizer
  American Society of Nephrology (Kidney week 2018)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] CKD患者において終末糖化産物（AGEs）は血管石灰化の発症に関与する.2018
- Author(s)
  長澤　肇、上田誠二、小林敬、金口泰彦、高橋敬子、薮内純子、鈴木祐介
- Organizer
  .第41回日本高血圧学会総会.
- Data Source
  KAKENHI-PROJECT-18K08251
[Presentation] 心腎連関におけるジメチルアルギニンの役割2011
- Author(s)
  上田誠二、奥田誠也
- Organizer
  日本腎臓学会西部学術大会
- Place of Presentation
  徳島
- Year and Date
  2011-09-30
- Data Source
  KAKENHI-PROJECT-23591210
[Presentation] Cardiorenal syndrome と ADMA2010
- Author(s)
  上田誠二
- Organizer
  第53回日本腎臓学会学術総会
- Place of Presentation
  神戸国際会議場
- Year and Date
  2010-06-18
- Data Source
  KAKENHI-PROJECT-20590969
[Presentation] 心腎連関 -そのリスクの評価と治療について-2010
- Author(s)
  上田誠二
- Organizer
  第40回日本腎臓学会西部学術大会
- Place of Presentation
  和歌山
- Data Source
  KAKENHI-PROJECT-20590969
[Presentation] 心腎連関とADMA2010
- Author(s)
  上田誠二
- Organizer
  第53回日本腎臓学会学術総会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-20590969
[Presentation] CKDの基盤病態としての血管内皮障害2010
- Author(s)
  上田誠二
- Organizer
  第31回日本臨床薬理学会年会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-20590969
[Presentation] 心腎連関の新規バイオマーカーとしてのADMA2009
- Author(s)
  上田誠二、山岸昌一、奥田誠也
- Organizer
  第39回日本腎臓学会西部学術大会
- Place of Presentation
  和歌山
- Data Source
  KAKENHI-PROJECT-20590969
[Presentation] ADMA is a novel marker for renal tissue damage in patients with IgA nephropathy2008
- Author(s)
  Hayashida A, Ueda S, et al
- Organizer
  The 4^<th> International Meeting on ADMA
- Place of Presentation
  オーストリア
- Year and Date
  2008-08-29
- Data Source
  KAKENHI-PROJECT-20590969
[Presentation] ADMA is a novel marker for renal tissue damage in patients with IgA nephropathy.2008
- Author(s)
  Hayashida A, Ueda S, et al.
- Organizer
  The 4th International Meeting on ADMA
- Place of Presentation
  Bregenz, Austria
- Year and Date
  2008-08-29
- Data Source
  KAKENHI-PROJECT-20590969
[Presentation] Possible involvement of AGE and MMP-2 in podocyte detachment and loss. Roma.2008
- Author(s)
  Fukami K, Takamiya Y, Yamagishi S, Ueda S, Takeuchi M, Okuda S
- Organizer
  Diabetologia
- Place of Presentation
  EASD
- Data Source
  KAKENHI-PROJECT-19590970
[Presentation] Possible involvement of AGE and MMP-2 in podocyte detachment and loss.2007
- Author(s)
  Fukami K, Takamiya Y, Yamagishi S, Ueda S, Takeuchi M, Okuda S
- Organizer
  Amsterdam. Diabetologia
- Place of Presentation
  EASD
- Data Source
  KAKENHI-PROJECT-19590970
[Presentation] Countering ADMA as a new pathway for renal disease progression2007
- Author(s)
  Ueda S
- Organizer
  欧州腎臓病学会(ERA-EDTA)
- Place of Presentation
  バルセロナ、スペイン
- Year and Date
  2007-06-22
- Data Source
  KAKENHI-PROJECT-18790582
[Presentation] Possible involvement of AGE and MMP-2 in podocyte detachment and loss2007
- Author(s)
  Kei Fukami, Sho-ichi Yamagishi, Seiji Ueda, Hiroshi Kawachi, Masayoshi Thkeuchi, Seiya Okuda
- Organizer
  The European Association for the Study of Diabetes
- Place of Presentation
  アムステルダム
- Year and Date
  2007-09-19
- Data Source
  KAKENHI-PROJECT-19590970
[Presentation] 心腎連関におけるジメチルアルギニンの役割
- Author(s)
  上田誠二、奥田誠也
- Organizer
  日本腎臓学会西部学術大会(招待講演)
- Place of Presentation
  徳島
- Data Source
  KAKENHI-PROJECT-23591210

1. OKUDA Seiya (80158823)

# of Collaborated Projects: 2 results

# of Collaborated Products: 37 results
2. FUKAMI Kei (80309781)

# of Collaborated Projects: 1 results

# of Collaborated Products: 19 results
3. 山岸昌一 (40281026)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
4. 中田真実 (40894499)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 鈴木仁 (10468572)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 鈴木祐介 (70372935)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 若林啓一 (60748565)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
8. MATSUI Takanori

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. KAJIMOTO Hidemi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 東元祐一郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 合田朋仁

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 甲斐久史

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 今泉勉

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

UEDA SEIJI 上田 誠二

Seiji Ueda 上田 誠二

UEDA Seiji 上田 誠二

Research Projects

Research Products

Co-Researchers

Roles of Irisin, a myokine in uremiac sarcopeniaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

急性腎障害におけるミネラルコルチコイド受容体を標的とした新規治療戦略の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

IgA腎症モデルマウスにおけるエンドセリン受容体拮抗薬による腎保護作用の解析

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Involvements of advanced glycation end products on the developments of peripheral arterial disease in CKD patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Role of ADMA in acute kidney injuryPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Missing link between metabolic syndrome and chronic kidney disease.?Role of asymmetric dimethylarginine-

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Role of asymmetric dimethylarginine in cardio-renal syndromePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Tubulointerstitial injury is exacerbated in streptozotocin-induced diabetic matrix metalloproteinase-2 knockout mice

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

ADMA metabolism and microvascular damage in chronic renal diseases

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

内因性一酸化窒素合成酵素酵素阻害物質蓄積抑制による慢性腎疾患進展予防Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

腎不全進展におけるasymmetric dimethylarginineの役割Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

ループス腎炎発症・進展におけるInterleukin-4(IL-4)の役割Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

生体内NO産生調整システムとしてのADMA-DDAH系Principal Investigator

Principal Investigator

UEDA SEIJI 上田誠二

Seiji Ueda 上田誠二

UEDA Seiji 上田誠二